Fundz

Lexaria Bioscience reported raising $3.5 Million in an initial SEC Form D filing, from an offering of $3.5 Million

PUBLIC · LEXXDec 19, 2025

Amount Raised

$3.5 Million

$3.5 Million sold, per SEC Form D (first sale Dec 16, 2025)

Round Type

Venture

KelownaOtherBiotechnologyHealthcare

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Lexaria Bioscience that raised within 45 days of this round, from Fundz verified event records.

  • Artelo Biosciences raised $500K on January 30, 2026.
  • Primmune Therapeutics raised $8.6M (Series B) on January 30, 2026.
  • CytoDyn raised $19M on January 30, 2026.
  • NeOnc Technologies raised $11M on January 29, 2026.
  • Elysium Therapeutics raised $7.5M (Convertible Note) on January 28, 2026.
  • Enveric Biosciences raised $1.5M on January 28, 2026.

Who to call at Lexaria Bioscience, and when

A new round usually means Lexaria Bioscience is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lexaria Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lexaria Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lexaria Bioscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lexaria Bioscience

Location

100 - 740 MCCURDY ROAD

Kelowna, British Columbia, Canada

About

Lexaria Bioscience Corp. is a global innovator in drug delivery platforms, focusing on improving the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral delivery. The company has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats, and operates a licensed in-house research laboratory. Additionally, the company holds a robust intellectual property portfolio with 39 patents granted and many patents pending worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lexaria Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsVanessa C., Head of Legal Department hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Lexaria Bioscience's next move

See what Strategic adds

Lexaria Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.